Magnesium-dependent kinase enzymes

Magnesium-dependent kinase enzymes are a diverse group of enzymes that catalyze phosphate transfer reactions, primarily from ATP to specific substrate molecules, and require magnesium ions (Mg²⁺) to facilitate this process[4][5][12]. Magnesium acts by stabilizing the negative charge on ATP phosphates, promoting proper substrate and nucleotide alignment, and inducing necessary structural rearrangements for catalysis[1][3][5]. Over 600 enzymes use Mg²⁺ as a cofactor, including well-known kinases such as protein kinase A, cyclin-dependent kinases, hexokinase, and many others[4][5]. Their biological roles are crucial in cellular signaling, metabolism, proliferation, and energy transduction, with dysfunction or dysregulation contributing to diseases such as cancer, metabolic disorder, and cardiovascular and neurological conditions[4][5][6]. While therapeutics do target individual magnesium-dependent kinases, "magnesium-dependent kinase enzyme" as a collective is not a therapeutically actionable unit but a functional classification. Additional Context: - Individual examples: CDK2 (Cyclin-dependent kinase 2) and Protein kinase A both require Mg²⁺ for optimal activity; CDK2 can cycle between one and two Mg²⁺ in the active site during catalysis, which is essential for proper phosphate transfer[1][3]. In addition, many metabolic kinases like hexokinase, phosphofructokinase, and pyruvate kinase are magnesium-dependent[4][5]. - Mechanistic details: Magnesium binds ATP and aligns its phosphates for transfer, induces conformational changes in both substrate and enzyme, and is sometimes involved in allosteric regulation or inhibitor binding[1][5][12]. - Therapeutic relevance: Kinase inhibitors (e.g., staurosporine, imatinib, palbociclib) target specific members of this enzyme group but not the class as a whole. Summary of naming issue: There is no single protein or unique gene called "magnesium-dependent kinase enzyme"; it is a generic, descriptive term. For actionable information, one would need to specify an individual kinase (e.g., "Cyclin-dependent kinase 2 (CDK2)"), since hundreds of different kinases rely on magnesium, each with their own disease associations, drugs, and therapeutic importance[4][5][12].

Other names

Mg²⁺-dependent kinasemagnesium-dependent protein kinasemagnesium-dependent enzymes

Most small-molecule kinase inhibitors act by blocking ATP binding, substrate binding, or altering kinase conformation (mechanisms are specific to individual kinase targets, not the entire group)